Please login to the form below

Not currently logged in
Email:
Password:

90TEN bolsters medical education team

Agency appoints Melanie Sobczyk and Mark Lakeram

Mark and MelHealthcare communications consultancy 90TEN has appointed Melanie Sobczyk and Mark Lakeram to its medical education team following a year of growth.

Sobczyk joins the agency as an associate director from Chameleon, where she was the group account director. Her new role will see her take responsibility for the medical education client services team.

Lakeram also joins the agency as its editorial director, a newly created role which will see him lead and shape the team responsible for delivering editorial excellence across the consultancy. He is a former pharmacist and has held an associate editorial director role at Medical Knowledge Group, the medical division of Hill+Knowlton Strategies.

Alison Doughty, managing director of medical education at 90TEN, said: “Out clients come to us for our scientific expertise and strategic acumen, and both Mark and Melanie have these in spades.

“I’m delighted to be working with such a strong and talented senior team during this very exciting time for us here at 90TEN.

10th August 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics